Intermittent point prevalence surveys on healthcare-associated infections, 2011 and 2016, in England: what are the surveillance and intervention priorities?

Henderson, K L; Saei, A; Freeman, R; Johnson, A P; Ashiru-Oredope, D; Gerver, S M; Hopkins, S

Henderson, K L; Saei, A; Freeman, R; Johnson, A P; Ashiru-Oredope, D; Gerver, S M; Hopkins, S.

Afiliación

Henderson KL; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK. Electronic address: Katherine.henderson@ukhsa.gov.uk.
Saei A; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.
Freeman R; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.
Johnson AP; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.
Ashiru-Oredope D; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.
Gerver SM; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.
Hopkins S; HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.

J Hosp Infect ; 140: 24-33, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37532196

Asunto(s)

Infección Hospitalaria; Medicina Estatal; Adulto; Humanos; Prevalencia; Infección Hospitalaria/epidemiología; Antibacterianos; Inglaterra/epidemiología

Palabras clave

England; Healthcare-associated; Prevalence; Survey; infection

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicina Estatal / Infección Hospitalaria Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: J Hosp Infect Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google